Sign in
Taking people in United StatesNo phase

Collects survey data from people with type 1 diabetes and their supporters

Gathers yearly survey information from people with type 1 diabetes and their supporters.

Key facts

Who runs it
T1D Exchange, United States
Where
Boston, United StatesSee the site
Trial code
Registry title
The T1D Exchange Registry
Status
Recruiting
People taking part
50,000 people, planned
Started
13 Dec 2018
Expected to end
31 Dec 2030
Type of study
Observational
Record updated
8 May 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people living in the United States who have type 1 diabetes. They must read and understand English.

Age
No age limit is stated. People younger than 18 years need parent or guardian consent.
Sex
All sexes can join.
Disease stage
A clinical diagnosis of type 1 diabetes.
Earlier treatment
People who do not use insulin cannot join, unless they have had a pancreatic or islet cell transplant.

Main reasons for not taking part

  • Does not use insulin and has not had a pancreatic or islet cell transplant
  • Cannot fully read and understand English
  • Does not currently live in the United States

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Clinical diagnosis of type 1 diabetes
  • Individuals younger than 18 years of age must have parent/guardian consent
  • Must be able to read and understand English
  • Currently living in the United States

Who cannot take part

  • Does not use insulin and has not had a pancreatic or islet cell transplant
  • Cannot fully read and understand English
  • Does not currently live in the United States

Where in United States

  • T1D ExchangeBoston, United StatesContact: Kelsie LaFerriereTaking people

About the trial

What the trial wants to find out

The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes.

Read full original descriptionShow less

To participate, you will be asked to:

* Read and sign an online informed consent form * Take a survey describing specific demographic and type 1 diabetes management information * Update your information annually * Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data

The group in the trial

  • Individuals diagnosed with type 1 diabetes

    T1D Exchange Registry is currently looking for participants: * Of all ages, genders, races, and ethnic groups * Living in the United States * Diagnosed with type 1 diabetes * Currently taking insulin or have had a pancreatic or islet cell transplant

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
The T1D Exchange Registry
Plain-language title
Collects survey data from people with type 1 diabetes and their supportersGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
8 May 2023